newsfilter
← Latest News
GlobeNewswire·

Chiasma to Participate in Two September Investor Conferences

NEEDHAM, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company utilizing its delivery platform technology to develop oral therapies to...